RESPONSE AFTER NON-FINAL ACTION - ENTERED
final action
on 21 Nov 2024
Last Applicant/ Owned by
DK-2200 København N
DK
Serial Number
79381991 filed on 21st Sep 2023
Registration Number
N/A
Correspondent Address
Stacy J. Grossman
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
GLX
Computer services, namely, on-site and remote management of information technology (IT) systems of others for the pharmaceutical and healthcare industries; medical and pharmacological research services; software as a service (SaaS) services featuring software platforms using artificial intelligence technology for diagnosing, predicting, prognosticating and monitoring medical conditions; DNA sequen Read More
Classification Information
Class [045]
Personal & Legal & Social Services
Health and safety risk management in the nature of security threat analysis for the protection of individuals; health and safety risk assessment services in the nature of security threat analysis for the protection of individuals; licensing of intellectual property; licensing of industrial property rights; legal services; intellectual property licensing services; licensing of intellectual property in the field of copyrights being legal services; licensing of intellectual property in the field of trademarks being legal services
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [042]
Computer & Software Services & Scientific Services
Computer services, namely, on-site and remote management of information technology (IT) systems of others for the pharmaceutical and healthcare industries; medical and pharmacological research services; software as a service (SaaS) services featuring software platforms using artificial intelligence technology for diagnosing, predicting, prognosticating and monitoring medical conditions; DNA sequencing technology research; blood analysis services for scientific research purposes; software as a service (SaaS) featuring software using machine learning technology for diagnosing, predicting, prognosticating and monitoring medical conditions; software as a service (SaaS) services featuring software using machine learning, deep learning and deep neural network technology for diagnosing, predicting, prognosticating and monitoring medical conditions
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable software for use in data management in the medical field; downloadable computer software relating to the medical field for use in data management; software as a medical device (SaMD), downloadable, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable computer software for use in medical decision support systems, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable health monitoring software; downloadable artificial intelligence software for healthcare, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable machine learning software for healthcare, namely, for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable system and system support software, and firmware for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence and machine learning software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable artificial intelligence software for analysis of diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable software for making remote medical diagnostics; downloadable machine learning software for diagnosing, predicting, prognosticating and monitoring medical conditions; downloadable machine learning software for analysis of medical data
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Injectable pharmaceuticals for inflammatory diseases; diagnostic reagents for medical use; biological reagents for medical use; chemical reagents for medical use; diagnostic chemical reagents for medical use; diagnostic biomarker reagents for medical purposes; reagents for analytical purposes being reagents for medical purposes; reagents for microbiological analysis being reagents for veterinary purposes; antibodies for medical and veterinary purposes; pharmaceutical drugs being pharmaceutical preparations for the treatment and prevention of inflammatory diseases; anti-cancer drugs being anti-cancer preparations; drugs for medical purposes being pharmaceutical preparations for the treatment and prevention of inflammatory diseases; pharmaceutical preparations for the treatment and prevention of inflammatory diseases; pharmaceutical and natural remedy preparations for the treatment and prevention of inflammatory diseases; pharmaceutical preparations for the prevention of autoimmune disorders; reagents for blood grouping for medical purposes; pharmaceutical preparations, namely, human immune globulinfor the treatment and prevention of inflammatory diseases; pharmaceutical preparations for regulating the immune system; pharmaceutical preparations for the treatment of immune system related diseases and disorders
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 79381991
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
Yes
66A Current
Yes
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 21st Nov 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 21st Nov 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 21st Nov 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 15th Jul 2024 | REFUSAL PROCESSED BY IB |
| 24th Jun 2024 | REFUSAL PROCESSED BY MPU |
| 24th Jun 2024 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| 05th Jun 2024 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| 17th May 2024 | NON-FINAL ACTION WRITTEN |
| 14th May 2024 | ASSIGNED TO EXAMINER |
| 25th Nov 2023 | NEW REPRESENTATIVE AT IB RECEIVED |